Company News
Lupin Launches Dapagliflozin-Metformin XR Tablets US
Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the US market following FDA ANDA approval.
The product is bioequivalent to AstraZeneca's Xigduo® XR and comes in fo
